Search

Displaying results 7961 - 7970 of 10000 in total
  1. Drug

    Feclobuzone

    go.drugbank.com/drugs/DB21131
    Experimental

    Feclobuzone is a small molecule drug. The usage of the INN stem '-zone' in the name indicates that Feclobuzone is a anti-inflammatory analgesic, phenylbutazone derivative.

  2. Drug

    Ketipramine

    go.drugbank.com/drugs/DB21245
    Experimental

    Ketipramine is a small molecule drug. The usage of the INN stem '-pramine' in the name indicates that Ketipramine is a substance of the imipramine group.

  3. Drug

    Bisfenazone

    go.drugbank.com/drugs/DB19838
    Experimental

    Bisfenazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Bisfenazone is a anti-inflammatory analgesic, phenylbutazone derivative.

  4. Drug

    Sulnidazole

    go.drugbank.com/drugs/DB19973
    Experimental

    Sulnidazole is a small molecule drug. The usage of the INN stem '-nidazole' in the name indicates that Sulnidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.

  5. Drug

    Almecillin

    go.drugbank.com/drugs/DB20069
    Experimental

    Almecillin is a small molecule drug. The usage of the INN stem '-cillin' in the name indicates that Almecillin is a antibiotic, 6-aminopenicillanic acid derivative.

  6. Drug

    Metamfazone

    go.drugbank.com/drugs/DB20145
    Experimental

    Metamfazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Metamfazone is a anti-inflammatory analgesic, phenylbutazone derivative.

  7. Drug

    Capadenoson

    go.drugbank.com/drugs/DB16118
    Investigational

    Capadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).

  8. Drug

    Enibarcimab

    go.drugbank.com/drugs/DB16730
    Investigational

    Enibarcimab is under investigation in clinical trial NCT03989531 (Adrecizumab in Cardiogenic Shock).

  9. Drug

    Hycanthone

    go.drugbank.com/drugs/DB14061
    Experimental

    Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE. Hycanthone was approved by the FDA in 1975 but is no longer used.

  10. Drug

    EGT-301

    go.drugbank.com/drugs/DB17649
    Experimental

    It consists of an adeno-associated viral vector serotype 9 (AAV9) containing the human Iduronate-2-sulfatase (I2S) transgene designed to restore I2S functional deficiency in patients with Hunter syndrome … EGT-301 is a gene therapy being investigated for Hunter Syndrome.